Does HUMAN IMMUNOGLOBULIN G Cause Product distribution issue? 279 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 279 reports of Product distribution issue have been filed in association with HUMAN IMMUNOGLOBULIN G (BIVIGAM). This represents 0.4% of all adverse event reports for HUMAN IMMUNOGLOBULIN G.
279
Reports of Product distribution issue with HUMAN IMMUNOGLOBULIN G
0.4%
of all HUMAN IMMUNOGLOBULIN G reports
5
Deaths
92
Hospitalizations
How Dangerous Is Product distribution issue From HUMAN IMMUNOGLOBULIN G?
Of the 279 reports, 5 (1.8%) resulted in death, 92 (33.0%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G. However, 279 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN IMMUNOGLOBULIN G Cause?
Headache (7,885)
Off label use (5,872)
Fatigue (5,423)
Nausea (4,454)
Sinusitis (4,409)
Pyrexia (4,076)
Drug ineffective (3,923)
Pruritus (3,775)
Dyspnoea (3,518)
Malaise (3,180)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
HUMAN C1-ESTERASE INHIBITOR (107)
Which HUMAN IMMUNOGLOBULIN G Alternatives Have Lower Product distribution issue Risk?
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN IMMUNOGLOBULIN G vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMAN IMMUNOGLOBULIN G vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G vs HUMAN RHO IMMUNE GLOBULIN